REFERENCES
- 1
Schiff D, Burgess T.
Editorial.
Semin Thromb Hemost.
2004;
30
601-602
- 2
Favaloro E J.
Editorial. Welcome to Seminars in Thrombosis and Hemostasis—2008!.
Semin Thromb Hemost.
2008;
34
1-2
- 3
Schiff D.
Eulogy. Eberhard Mammen, M.D. 1930–2008.
Semin Thromb Hemost.
2008;
34
305-306
- 4
Favaloro E J.
Editorial.
Semin Thromb Hemost.
2008;
34
307-308
- 5
Favaloro E J.
Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the
closing issue for 2008.
Semin Thromb Hemost.
2008;
34
693-696
- 6
Prasad A, Kwaan H C.
In memoriam: a tribute to Eberhard F Mammen, M.D. (1930–2008).
Semin Thromb Hemost.
2008;
34
697-698
- 7
Favaloro E J.
A tribute to Eberhard F. Mammen, M.D. (1930–2008).
Semin Thromb Hemost.
2008;
34(8)
703-707
- 8
Favaloro E J.
Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for
2009.
Semin Thromb Hemost.
2009;
35
1-2
- 9
Favaloro E J.
Measuring the quality of journals and journal articles: the impact factor tells but
a portion of the story.
Semin Thromb Hemost.
2008;
34(1)
7-25
- 10
Favaloro E J.
The Journal Impact Factor: don't expect its demise any time soon.
Clin Chem Lab Med.
2009;
47(11)
1319-1324
- 11
Esmon C T.
Inflammation and the activated protein C anticoagulant pathway.
Semin Thromb Hemost.
2006;
32(suppl 1)
49-60
- 12
Østerud B, Bjørklid E.
Sources of tissue factor.
Semin Thromb Hemost.
2006;
32(1)
11-23
- 13
Rak J, Milsom C, May L, Klement P, Yu J.
Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor
progression, tumor neovascularization, and cancer coagulopathy.
Semin Thromb Hemost.
2006;
32(1)
54-70
- 14
Versteeg H H, Ruf W.
Emerging insights in tissue factor-dependent signaling events.
Semin Thromb Hemost.
2006;
32(1)
24-32
- 15
Ruf W, Mueller B M.
Thrombin generation and the pathogenesis of cancer.
Semin Thromb Hemost.
2006;
32(suppl 1)
61-68
- 16
Favaloro E J.
Laboratory identification of von Willebrand disease: technical and scientific perspectives.
Semin Thromb Hemost.
2006;
32(5)
456-471
- 17
Levi M, van der Poll T, ten Cate H.
Tissue factor in infection and severe inflammation.
Semin Thromb Hemost.
2006;
32(1)
33-39
- 18
Davie E W, Kulman J D.
An overview of the structure and function of thrombin.
Semin Thromb Hemost.
2006;
32(suppl 1)
3-15
- 19
Tefferi A, Elliott M.
Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the
role of leukocytes and JAK2V617F.
Semin Thromb Hemost.
2007;
33(4)
313-320
- 20
Michiels J J, De Raeve H, Berneman Z et al..
The 2001 World Health Organization and updated European clinical and pathological
criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative
chronic myeloproliferative disorders.
Semin Thromb Hemost.
2006;
32(4 Pt 2)
307-340
- 21
Hedner U.
Mechanism of action of factor VIIa in the treatment of coagulopathies.
Semin Thromb Hemost.
2006;
32(suppl 1)
77-85
- 22
Roberts H R, Hoffman M, Monroe D M.
A cell-based model of thrombin generation.
Semin Thromb Hemost.
2006;
32(suppl 1)
32-38
- 23
Kucher N, Goldhaber S Z.
Risk stratification of acute pulmonary embolism.
Semin Thromb Hemost.
2006;
32(8)
838-847
- 24
Michiels J J, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and
bleeding complications, and the molecular etiology of essential thrombocythemia and
polycythemia vera: therapeutic implications.
Semin Thromb Hemost.
2006;
32(3)
174-207
- 25
Lawson J H.
The clinical use and immunologic impact of thrombin in surgery.
Semin Thromb Hemost.
2006;
32(suppl 1)
98-110
- 26
de Lamirande E.
Semenogelin, the main protein of the human semen coagulum, regulates sperm function.
Semin Thromb Hemost.
2007;
33(1)
60-68
- 27
Favaloro E J.
The utility of the PFA-100 in the identification of von Willebrand disease: a concise
review.
Semin Thromb Hemost.
2006;
32(5)
537-545
- 28
Kavanagh D, Goodship T H.
Membrane cofactor protein and factor I: mutations and transplantation.
Semin Thromb Hemost.
2006;
32(2)
155-159
- 29
Siegel-Axel D I, Gawaz M.
Platelets and endothelial cells.
Semin Thromb Hemost.
2007;
33(2)
128-135
- 30
Qu L, Kiss J E.
Thrombotic microangiopathy in transplantation and malignancy.
Semin Thromb Hemost.
2005;
31(6)
691-699
- 31
Tilley R, Mackman N.
Tissue factor in hemostasis and thrombosis.
Semin Thromb Hemost.
2006;
32(1)
5-10
- 32
Zakarija A, Bennett C.
Drug-induced thrombotic microangiopathy.
Semin Thromb Hemost.
2005;
31(6)
681-690
- 33
Ferro V, Dredge K, Liu L et al..
PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
Semin Thromb Hemost.
2007;
33(5)
557-568
- 34
Favaloro E J, Bonar R, Kershaw G et al..
Reducing errors in identification of von Willebrand disease: the experience of the
Royal College of Pathologists of Australasia quality assurance program.
Semin Thromb Hemost.
2006;
32(5)
505-513
- 35
Rock G.
The management of thrombotic thrombocytopenic purpura in 2005.
Semin Thromb Hemost.
2005;
31(6)
709-716
- 36
Griesshammer M.
Risk factors for thrombosis and bleeding and their influence on therapeutic decisions
in patients with essential thrombocythemia.
Semin Thromb Hemost.
2006;
32(4 Pt 2)
372-380
- 37
Girolami B, Girolami A.
Heparin-induced thrombocytopenia: a review.
Semin Thromb Hemost.
2006;
32(8)
803-809
- 38
Budde U, Metzner H J, Müller H G.
Comparative analysis and classification of von Willebrand factor/factor VIII concentrates:
impact on treatment of patients with von Willebrand disease.
Semin Thromb Hemost.
2006;
32(6)
626-635
- 39
Ageno W, Squizzato A, Garcia D, Imberti D.
Epidemiology and risk factors of venous thromboembolism.
Semin Thromb Hemost.
2006;
32(7)
651-658
- 40
Hayward C P, Eikelboom J.
Platelet function testing: quality assurance.
Semin Thromb Hemost.
2007;
33(3)
273-282
Emmanuel J FavaloroPh.D. M.A.I.M.S.
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR)
Westmead Hospital, WSAHS, Westmead, Australia
Email: emmanuel.favaloro@swahs.health.nsw.gov.au
